Loading…
Wednesday, June 27 • 2:00pm - 3:15pm
#359: IMEDS: A Collaboration Based on the FDA's Sentinel Initiative

Sign up or log in to save this to your schedule and see who's attending!

Component Type: Forum
Level: Basic
CE: ACPE 1.25 Knowledge UAN: 0286-0000-18-656-L04-P; CME 1.25; IACET 1.25; RN 1.25

This forum will educate industry on how, when, and why, utilizing IMEDS may be helpful to answering drug safety and other types of pharmacovigilance research questions.

Learning Objectives

Explain the IMEDS program and the role of the Reagan-Udall Foundation for the FDA; Distinguish the IMEDS database from other safety study databases; Illustrate the purpose and uses of the IMEDS program.

Chair

June Wasser, MA

Speaker

Panelist
Cheryl Walraven, PhD

IMEDS Analytic Center: Supporting the IMEDS Research Portfolio
Jeffrey Brown, PhD, MA

Panelist
Claudia A Salinas, PhD



Speakers
JB

Jeffrey Brown

Associate Professor, Department of Population Medicine, Harvard Pilgrim Health Care Institute/Harvard Medical School
Dr. Brown is an Associate Professor in the Department of Population Medicine, Harvard Medical School and the Harvard Pilgrim Health Care Institute. His primary research activities involve new approaches to facilitate large-scale multi-institutional research and the use of distributed... Read More →
CS

Claudia Salinas

Senior Research Scientist, GPS Pharmacoepidemiology, Eli Lilly and Company
Dr. Salinas works in Global Patient Safety at Eli Lilly and Company. She received her doctorate in Epidemiology at the University of Washington in prostate cancer risk and polymorphisms in IL6 pathway genes. Since 2013 she has focused on epidemiologic methods relevant to pharmacoepidemiology... Read More →
avatar for Cheryl Walraven

Cheryl Walraven

Director, Informatics, Aetna
Cheryl leads an Aetna team responsible for the FDA’s Sentinel public health initiative and other distributed research networks (DRNs) including AMCP’s BBCIC and Reagan Udall’s IMEDS. Cheryl joined Aetna to reduce healthcare disparities through program evaluation and RCTs in... Read More →
avatar for June Wasser

June Wasser

Executive Director, Reagan-Udall Foundation For the FDA
June Wasser is the Executive Director of the Reagan-Udall Foundation for the FDA and in this role leads the direction of the Foundation and implementation of its programs. She is responsible for building strategic relationships throughout the public-private sector with the goal of... Read More →


Wednesday June 27, 2018 2:00pm - 3:15pm
Room 253C Boston Convention and Exhibition Center 415 Summer Street, Boston, MA 02210 USA